{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:34:23Z","timestamp":1793295263692,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-05327-z","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:06:45Z","timestamp":1700554005000},"page":"1021-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review"],"prefix":"10.1007","volume":"183","author":[{"given":"Yu-Yu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8918-6718","authenticated-orcid":false,"given":"Fei-Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"5327_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10\u201326. https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0","journal-title":"Genet Med"},{"key":"5327_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/jpc.14546","volume":"55","author":"J Mackay","year":"2019","unstructured":"Mackay J, McCallum Z, Ambler GR et al (2019) Requirements for improving health and well-being of children with Prader-Willi syndrome and their families. J Paediatr Child Health 55:1029\u20131037. https:\/\/doi.org\/10.1111\/jpc.14546","journal-title":"J Paediatr Child Health"},{"key":"5327_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13023-022-02302-z","volume":"17","author":"D Yang-Li","year":"2022","unstructured":"Yang-Li D, Fei-Hong L, Hui-Wen Z et al (2022) Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China. Orphanet J Rare Dis 17:221. https:\/\/doi.org\/10.1186\/s13023-022-02302-z","journal-title":"Orphanet J Rare Dis"},{"key":"5327_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4274\/Jcrpe.1228","volume":"6","author":"Z Aycan","year":"2014","unstructured":"Aycan Z, Ba\u015f VN (2014) Prader-Willi syndrome and growth hormone deficiency. J Clin Res Pediatr Endocrinol 6:62\u201367. https:\/\/doi.org\/10.4274\/Jcrpe.1228","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5327_CR5","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3390\/jcm11092496","volume":"11","author":"LN Grootjen","year":"2022","unstructured":"Grootjen LN, Trueba-Timmermans DJ, Damen L et al (2022) Long-term growth hormone treatment of children with PWS: the earlier the start, the better the outcomes? J Clin Med 11:2496. https:\/\/doi.org\/10.3390\/jcm11092496","journal-title":"J Clin Med"},{"key":"5327_CR6","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","volume":"98","author":"CL Deal","year":"2013","unstructured":"Deal CL, Tony M, H\u00f6ybye C et al (2013) Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98:E1072-1087. https:\/\/doi.org\/10.1210\/jc.2012-3888","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR7","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.neubiorev.2012.05.005","volume":"36","author":"L Reus","year":"2012","unstructured":"Reus L, van Vlimmeren LA, Staal JB et al (2012) The effect of growth hormone treatment or physical training on motor performance in Prader-Willi syndrome: a systematic review. Neurosci Biobehav Rev 36:1817\u20131838. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.05.005","journal-title":"Neurosci Biobehav Rev"},{"key":"5327_CR8","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/jcm11061592","volume":"11","author":"A Ayet-Roger","year":"2022","unstructured":"Ayet-Roger A, Joga-Elvira L, Caix\u00e0s A, Corripio R (2022) Cognitive and adaptive effects of early growth hormone treatment in Prader-Willi syndrome patients: a cohort study. J Clin Med 11:1592. https:\/\/doi.org\/10.3390\/jcm11061592","journal-title":"J Clin Med"},{"key":"5327_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0022-3476(99)70418-x","volume":"134","author":"AL Carrel","year":"1999","unstructured":"Carrel AL, Myers SE, Whitman BY, Allen DB (1999) Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 134:215\u2013221. https:\/\/doi.org\/10.1016\/s0022-3476(99)70418-x","journal-title":"J Pediatr"},{"key":"5327_CR10","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1210\/jc.2018-00687","volume":"103","author":"SH Donze","year":"2018","unstructured":"Donze SH, Damen L, Mahabier EF, Hokken-Koelega ACS (2018) Improved mental and motor development during 3 years of GH treatment in very young children with Prader-Willi syndrome. J Clin Endocrinol Metab 103:3714\u20133719. https:\/\/doi.org\/10.1210\/jc.2018-00687","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0929-6646(09)60303-X","volume":"106","author":"S-G Shu","year":"2007","unstructured":"Shu S-G, Chien S, Wu Y-C et al (2007) Anthropometric and intellectual evaluation of individuals with Prader-Willi syndrome. J Formos Med Assoc 106:509\u2013512. https:\/\/doi.org\/10.1016\/S0929-6646(09)60303-X","journal-title":"J Formos Med Assoc"},{"key":"5327_CR12","first-page":"436","volume":"33","author":"C-M Chen","year":"2010","unstructured":"Chen C-M, Chen C-L, Hou J-W et al (2010) Developmental profiles and mentality in preschool children with Prader-Willi syndrome: a preliminary study. Chang Gung Med J 33:436\u2013442","journal-title":"Chang Gung Med J"},{"key":"5327_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1365-2788.2010.01251.x","volume":"54","author":"P Copet","year":"2010","unstructured":"Copet P, Jauregi J, Laurier V et al (2010) Cognitive profile in a large french cohort of adults with Prader-Willi syndrome: differences between genotypes. J Intellect Disabil Res 54:204\u2013215. https:\/\/doi.org\/10.1111\/j.1365-2788.2010.01251.x","journal-title":"J Intellect Disabil Res"},{"key":"5327_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcomdis.2012.12.001","volume":"46","author":"A Dimitropoulos","year":"2013","unstructured":"Dimitropoulos A, Ferranti A, Lemler M (2013) Expressive and receptive language in Prader-Willi syndrome: report on genetic subtype differences. J Commun Disord 46:193\u2013201. https:\/\/doi.org\/10.1016\/j.jcomdis.2012.12.001","journal-title":"J Commun Disord"},{"key":"5327_CR15","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/00004583-199211000-00022","volume":"31","author":"EM Dykens","year":"1992","unstructured":"Dykens EM, Hodapp RM, Walsh K, Nash LJ (1992) Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 31:1125\u20131130. https:\/\/doi.org\/10.1097\/00004583-199211000-00022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"5327_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1365-2788.2006.00883.x","volume":"51","author":"J Jauregi","year":"2007","unstructured":"Jauregi J, Arias C, Vegas O et al (2007) A neuropsychological assessment of frontal cognitive functions in Prader-Willi syndrome. J Intellect Disabil Res 51:350\u2013365. https:\/\/doi.org\/10.1111\/j.1365-2788.2006.00883.x","journal-title":"J Intellect Disabil Res"},{"key":"5327_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3940(02)00377-4","volume":"327","author":"JEA Stauder","year":"2002","unstructured":"Stauder JEA, Brinkman MJR, Curfs LMG (2002) Multi-modal P3 deflation of event-related brain activity in Prader-Willi syndrome. Neurosci Lett 327:99\u2013102. https:\/\/doi.org\/10.1016\/S0304-3940(02)00377-4","journal-title":"Neurosci Lett"},{"key":"5327_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001709","volume":"3","author":"F Ding","year":"2008","unstructured":"Ding F, Li HH, Zhang S et al (2008) SnoRNA Snord116 (Pwcr1\/MBII-85) deletion causes growth deficiency and hyperphagia in mice. PLoS ONE 3:e1709. https:\/\/doi.org\/10.1371\/journal.pone.0001709","journal-title":"PLoS ONE"},{"key":"5327_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neubiorev.2016.09.013","volume":"72","author":"J Whittington","year":"2017","unstructured":"Whittington J, Holland A (2017) Cognition in people with Prader-Willi syndrome: insights into genetic influences on cognitive and social development. Neurosci Biobehav Rev 72:153\u2013167. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.09.013","journal-title":"Neurosci Biobehav Rev"},{"key":"5327_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1352\/2008.113:342-355","volume":"113","author":"BN Verdine","year":"2008","unstructured":"Verdine BN, Troseth GL, Hodapp RM, Dykens EM (2008) Strategies and correlates of jigsaw puzzle and visuospatial performance by persons with Prader-Willi syndrome. Am J Ment Retard 113:343\u2013355. https:\/\/doi.org\/10.1352\/2008.113:342-355","journal-title":"Am J Ment Retard"},{"key":"5327_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/EJE-19-0479","volume":"182","author":"SH Donze","year":"2020","unstructured":"Donze SH, Damen L, Mahabier EF, Hokken-Koelega ACS (2020) Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment. Eur J Endocrinol 182:405\u2013411. https:\/\/doi.org\/10.1530\/EJE-19-0479","journal-title":"Eur J Endocrinol"},{"key":"5327_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107320","volume":"9","author":"A Lukoshe","year":"2014","unstructured":"Lukoshe A, Hokken-Koelega AC, van der Lugt A, White T (2014) Reduced cortical complexity in children with Prader-Willi syndrome and its association with cognitive impairment and developmental delay. PLoS ONE 9:e107320. https:\/\/doi.org\/10.1371\/journal.pone.0107320","journal-title":"PLoS ONE"},{"key":"5327_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1866-1955-5-31","volume":"5","author":"A Lukoshe","year":"2013","unstructured":"Lukoshe A, White T, Schmidt MN et al (2013) Divergent structural brain abnormalities between different genetic subtypes of children with Prader-Willi syndrome. J Neurodev Disord 5:31. https:\/\/doi.org\/10.1186\/1866-1955-5-31","journal-title":"J Neurodev Disord"},{"key":"5327_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.nicl.2017.12.027","volume":"17","author":"KE Manning","year":"2017","unstructured":"Manning KE, Tait R, Suckling J, Holland AJ (2017) Grey matter volume and cortical structure in Prader-Willi syndrome compared to typically developing young adults. Neuroimage Clin 17:899\u2013909. https:\/\/doi.org\/10.1016\/j.nicl.2017.12.027","journal-title":"Neuroimage Clin"},{"issue":"Pt 1","key":"5327_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.1365-2788.2000.00250.x","volume":"44","author":"E Roof","year":"2000","unstructured":"Roof E, Stone W, MacLean W et al (2000) Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res 44(Pt 1):25\u201330. https:\/\/doi.org\/10.1046\/j.1365-2788.2000.00250.x","journal-title":"J Intellect Disabil Res"},{"key":"5327_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/jir.12197","volume":"59","author":"ST Lo","year":"2015","unstructured":"Lo ST, Collin PJL, Hokken-Koelega ACS (2015) Visual-motor integration in children with Prader-Willi syndrome. J Intellect Disabil Res 59:827\u2013834. https:\/\/doi.org\/10.1111\/jir.12197","journal-title":"J Intellect Disabil Res"},{"key":"5327_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1542\/peds.113.3.565","volume":"113","author":"MG Butler","year":"2004","unstructured":"Butler MG, Bittel DC, Kibiryeva N et al (2004) Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 113:565\u2013573. https:\/\/doi.org\/10.1542\/peds.113.3.565","journal-title":"Pediatrics"},{"key":"5327_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jcpp.12601","volume":"58","author":"EM Dykens","year":"2017","unstructured":"Dykens EM, Roof E, Hunt-Hawkins H (2017) Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. J Child Psychol Psychiatry 58:64\u201374. https:\/\/doi.org\/10.1111\/jcpp.12601","journal-title":"J Child Psychol Psychiatry"},{"key":"5327_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1469-7610.2005.01520.x","volume":"46","author":"KM Milner","year":"2005","unstructured":"Milner KM, Craig EE, Thompson RJ et al (2005) Prader-Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry 46:1089\u20131096. https:\/\/doi.org\/10.1111\/j.1469-7610.2005.01520.x","journal-title":"J Child Psychol Psychiatry"},{"key":"5327_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13052-022-01319-1","volume":"48","author":"L Zhang","year":"2022","unstructured":"Zhang L, Liu X, Zhao Y et al (2022) Genetic subtypes and phenotypic characteristics of 110 patients with Prader-Willi syndrome. Ital J Pediatr 48:121. https:\/\/doi.org\/10.1186\/s13052-022-01319-1","journal-title":"Ital J Pediatr"},{"key":"5327_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1098\/rstb.2002.1209","volume":"358","author":"EL Hill","year":"2003","unstructured":"Hill EL, Frith U (2003) Understanding autism: insights from mind and brain. Philos Trans R Soc Lond B Biol Sci 358:281\u2013289. https:\/\/doi.org\/10.1098\/rstb.2002.1209","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"5327_CR32","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/brain\/awl066","volume":"129","author":"LE Campbell","year":"2006","unstructured":"Campbell LE, Daly E, Toal F et al (2006) Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 129:1218\u20131228. https:\/\/doi.org\/10.1093\/brain\/awl066","journal-title":"Brain"},{"key":"5327_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41576-021-00348-6","volume":"22","author":"ES Oh","year":"2021","unstructured":"Oh ES, Petronis A (2021) Origins of human disease: the chrono-epigenetic perspective. Nat Rev Genet 22:533\u2013546. https:\/\/doi.org\/10.1038\/s41576-021-00348-6","journal-title":"Nat Rev Genet"},{"key":"5327_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1044\/1058-0360(2002\/033)","volume":"11","author":"BA Lewis","year":"2002","unstructured":"Lewis BA, Freebairn L, Heeger S, Cassidy SB (2002) Speech and language skills of individuals with Prader-Willi syndrome. Am J Speech Lang Pathol 11:285\u2013294. https:\/\/doi.org\/10.1044\/1058-0360(2002\/033)","journal-title":"Am J Speech Lang Pathol"},{"key":"5327_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ridd.2019.01.012","volume":"88","author":"J Pansy","year":"2019","unstructured":"Pansy J, Barones C, Urlesberger B et al (2019) Early motor and pre-linguistic verbal development in Prader-Willi syndrome - a case report. Res Dev Disabil 88:16\u201321. https:\/\/doi.org\/10.1016\/j.ridd.2019.01.012","journal-title":"Res Dev Disabil"},{"key":"5327_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s0270-3092(86)80018-2","volume":"7","author":"S Gabel","year":"1986","unstructured":"Gabel S, Tarter RE, Gavaler J et al (1986) Neuropsychological capacity of Prader-Willi children: general and specific aspects of impairment. Appl Res Ment Retard 7:459\u2013466. https:\/\/doi.org\/10.1016\/s0270-3092(86)80018-2","journal-title":"Appl Res Ment Retard"},{"key":"5327_CR37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1542\/peds.74.2.282","volume":"74","author":"DW Teele","year":"1984","unstructured":"Teele DW, Klein JO, Rosner BA (1984) Otitis media with effusion during the first three years of life and development of speech and language. Pediatrics 74:282\u2013287","journal-title":"Pediatrics"},{"key":"5327_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fped.2018.00102","volume":"6","author":"A Morel","year":"2018","unstructured":"Morel A, Peyroux E, Leleu A et al (2018) Overview of social cognitive dysfunctions in rare developmental syndromes with psychiatric phenotype. Front Pediatr 6:102. https:\/\/doi.org\/10.3389\/fped.2018.00102","journal-title":"Front Pediatr"},{"key":"5327_CR39","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1016\/j.ridd.2013.05.024","volume":"34","author":"ST Lo","year":"2013","unstructured":"Lo ST, Siemensma E, Collin P, Hokken-Koelega A (2013) Impaired theory of mind and symptoms of autism spectrum disorder in children with Prader-Willi syndrome. Res Dev Disabil 34:2764\u20132773. https:\/\/doi.org\/10.1016\/j.ridd.2013.05.024","journal-title":"Res Dev Disabil"},{"key":"5327_CR40","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/ajmg.a.61293","volume":"179","author":"MG Butler","year":"2019","unstructured":"Butler MG, Matthews NA, Patel N et al (2019) Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index. Am J Med Genet A 179:1826\u20131835. https:\/\/doi.org\/10.1002\/ajmg.a.61293","journal-title":"Am J Med Genet A"},{"key":"5327_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ajmg.b.32022","volume":"159B","author":"RA Honea","year":"2012","unstructured":"Honea RA, Holsen LM, Lepping RJ et al (2012) The neuroanatomy of genetic subtype differences in Prader-Willi syndrome. Am J Med Genet B Neuropsychiatr Genet 159B:243\u2013253. https:\/\/doi.org\/10.1002\/ajmg.b.32022","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"5327_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00439-011-0970-4","volume":"130","author":"RD Burnside","year":"2011","unstructured":"Burnside RD, Pasion R, Mikhail FM et al (2011) Microdeletion\/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 130:517\u2013528. https:\/\/doi.org\/10.1007\/s00439-011-0970-4","journal-title":"Hum Genet"},{"key":"5327_CR43","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1016\/j.ridd.2013.05.043","volume":"34","author":"L Reus","year":"2013","unstructured":"Reus L, Pelzer BJ, Otten BJ et al (2013) Growth hormone combined with child-specific motor training improves motor development in infants with Prader-Willi syndrome: a randomized controlled trial. Res Dev Disabil 34:3092\u20133103. https:\/\/doi.org\/10.1016\/j.ridd.2013.05.043","journal-title":"Res Dev Disabil"},{"key":"5327_CR44","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1542\/peds.91.2.398","volume":"91","author":"VA Holm","year":"1993","unstructured":"Holm VA, Cassidy SB, Butler MG et al (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 91:398\u2013402","journal-title":"Pediatrics"},{"key":"5327_CR45","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neubiorev.2010.10.015","volume":"35","author":"L Reus","year":"2011","unstructured":"Reus L, Zwarts M, van Vlimmeren LA et al (2011) Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning. Neurosci Biobehav Rev 35:956\u2013969. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.10.015","journal-title":"Neurosci Biobehav Rev"},{"key":"5327_CR46","doi-asserted-by":"publisher","first-page":"e1619","DOI":"10.1542\/peds.2013-3607","volume":"134","author":"L Reus","year":"2014","unstructured":"Reus L, Pillen S, Pelzer BJ et al (2014) Growth hormone therapy, muscle thickness, and motor development in Prader-Willi syndrome: an RCT. Pediatrics 134:e1619-1627. https:\/\/doi.org\/10.1542\/peds.2013-3607","journal-title":"Pediatrics"},{"key":"5327_CR47","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.3390\/jcm10153250","volume":"10","author":"K Pellikaan","year":"2021","unstructured":"Pellikaan K, Rosenberg AGW, Davidse K et al (2021) Effects of childhood multidisciplinary care and growth hormone treatment on health problems in adults with Prader-Willi syndrome. J Clin Med 10:3250. https:\/\/doi.org\/10.3390\/jcm10153250","journal-title":"J Clin Med"},{"key":"5327_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/17446651.2021.1898375","volume":"16","author":"A Salvatoni","year":"2021","unstructured":"Salvatoni A, Nosetti L, Salvatore S, Agosti M (2021) Benefits of multidisciplinary care in Prader-Willi syndrome. Expert Rev Endocrinol Metab 16:63\u201371. https:\/\/doi.org\/10.1080\/17446651.2021.1898375","journal-title":"Expert Rev Endocrinol Metab"},{"key":"5327_CR49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","volume":"22","author":"P Burman","year":"2001","unstructured":"Burman P, Ritz\u00e9n EM, Lindgren AC (2001) Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev 22:787\u2013799. https:\/\/doi.org\/10.1210\/edrv.22.6.0447","journal-title":"Endocr Rev"},{"key":"5327_CR50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.pcl.2015.03.004","volume":"62","author":"L Kalsner","year":"2015","unstructured":"Kalsner L, Chamberlain SJ (2015) Prader-Willi, Angelman, and 15q11-q13 duplication syndromes. Pediatr Clin North Am 62:587\u2013606. https:\/\/doi.org\/10.1016\/j.pcl.2015.03.004","journal-title":"Pediatr Clin North Am"},{"key":"5327_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000374113","volume":"83","author":"NE Bakker","year":"2015","unstructured":"Bakker NE, Siemensma EPC, Koopman C, Hokken-Koelega ACS (2015) Dietary energy intake, body composition and resting energy expenditure in prepubertal children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial. Horm Res Paediatr 83:321\u2013331. https:\/\/doi.org\/10.1159\/000374113","journal-title":"Horm Res Paediatr"},{"key":"5327_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/apa.12898","volume":"104","author":"C H\u00f6ybye","year":"2015","unstructured":"H\u00f6ybye C (2015) Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition. Acta Paediatr 104:422\u2013427. https:\/\/doi.org\/10.1111\/apa.12898","journal-title":"Acta Paediatr"},{"key":"5327_CR53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13023-019-1195-1","volume":"14","author":"A Yang","year":"2019","unstructured":"Yang A, Choi J-H, Sohn YB et al (2019) Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial. Orphanet J Rare Dis 14:216. https:\/\/doi.org\/10.1186\/s13023-019-1195-1","journal-title":"Orphanet J Rare Dis"},{"key":"5327_CR54","doi-asserted-by":"publisher","unstructured":"Noordam C, Stephan A, Eiholzer U (2023) Lean body mass in boys with Prader-Willi syndrome increases normally during spontaneous and induced puberty. J Clin Endocrinol Metab dgad101. https:\/\/doi.org\/10.1210\/clinem\/dgad101","DOI":"10.1210\/clinem\/dgad101"},{"key":"5327_CR55","doi-asserted-by":"publisher","unstructured":"Stipan\u010di\u0107 G, Po\u017egaj \u0160epec M, La Grasta Saboli\u0107 L (2018) Effect of growth hormone therapy in children with Prader-Willi syndrome - our first experiences. Acta Clin Croat 57:744\u2013755. https:\/\/doi.org\/10.20471\/acc.2018.57.04.17","DOI":"10.20471\/acc.2018.57.04.17"},{"key":"5327_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13633-020-00090-6","volume":"2020","author":"M Angulo","year":"2020","unstructured":"Angulo M, Abuzzahab MJ, Pietropoli A et al (2020) Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program\u00ae and NordiNet\u00ae International Outcome Study. Int J Pediatr Endocrinol 2020:20. https:\/\/doi.org\/10.1186\/s13633-020-00090-6","journal-title":"Int J Pediatr Endocrinol"},{"key":"5327_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13023-020-01527-0","volume":"15","author":"L Magill","year":"2020","unstructured":"Magill L, Laemmer C, Woelfle J et al (2020) Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome. Orphanet J Rare Dis 15:283. https:\/\/doi.org\/10.1186\/s13023-020-01527-0","journal-title":"Orphanet J Rare Dis"},{"key":"5327_CR58","doi-asserted-by":"publisher","unstructured":"Cheng R-Q, Ying Y-Q, Qiu Z-Q et al (2022) Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader\u2013Willi syndrome. World J Pediatr 1\u201312. https:\/\/doi.org\/10.1007\/s12519-022-00653-y","DOI":"10.1007\/s12519-022-00653-y"},{"key":"5327_CR59","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3390\/jcm10143176","volume":"10","author":"A Lecka-Ambroziak","year":"2021","unstructured":"Lecka-Ambroziak A, Wysocka-Mincewicz M, Dole\u017cal-O\u0142tarzewska K et al (2021) Effects of recombinant human growth hormone treatment, depending on the therapy start in different nutritional phases in paediatric patients with Prader-Willi syndrome: a Polish multicentre study. J Clin Med 10:3176. https:\/\/doi.org\/10.3390\/jcm10143176","journal-title":"J Clin Med"},{"key":"5327_CR60","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41436-021-01185-y","volume":"23","author":"S Eddiry","year":"2021","unstructured":"Eddiry S, Diene G, Molinas C et al (2021) SNORD116 and growth hormone therapy impact IGFBP7 in Prader-Willi syndrome. Genet Med 23:1664\u20131672. https:\/\/doi.org\/10.1038\/s41436-021-01185-y","journal-title":"Genet Med"},{"key":"5327_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrendo.2013.78","volume":"9","author":"F Nyberg","year":"2013","unstructured":"Nyberg F, Hallberg M (2013) Growth hormone and cognitive function. Nat Rev Endocrinol 9:357\u2013365. https:\/\/doi.org\/10.1038\/nrendo.2013.78","journal-title":"Nat Rev Endocrinol"},{"key":"5327_CR62","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/cen.14635","volume":"96","author":"M Koizumi","year":"2022","unstructured":"Koizumi M, Konishi A, Etani Y et al (2022) Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status. Clin Endocrinol (Oxf) 96:346\u2013352. https:\/\/doi.org\/10.1111\/cen.14635","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5327_CR63","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/genes11111250","volume":"11","author":"AS Montes","year":"2020","unstructured":"Montes AS, Osann KE, Gold JA et al (2020) Genetic subtype-phenotype analysis of growth hormone treatment on psychiatric behavior in Prader-Willi syndrome. Genes (Basel) 11:1250. https:\/\/doi.org\/10.3390\/genes11111250","journal-title":"Genes (Basel)"},{"key":"5327_CR64","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1210\/jc.2012-1182","volume":"97","author":"EPC Siemensma","year":"2012","unstructured":"Siemensma EPC, Lind T-d, van Wijngaarden RFA, Festen DAM et al (2012) Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab 97:2307\u20132314. https:\/\/doi.org\/10.1210\/jc.2012-1182","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1677\/JOE-09-0323","volume":"204","author":"E Nieves-Martinez","year":"2010","unstructured":"Nieves-Martinez E, Sonntag WE, Wilson A et al (2010) Early-onset GH deficiency results in spatial memory impairment in mid-life and is prevented by GH supplementation. J Endocrinol 204:31\u201336. https:\/\/doi.org\/10.1677\/JOE-09-0323","journal-title":"J Endocrinol"},{"key":"5327_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2019-000630","volume":"4","author":"C de Passone","year":"2020","unstructured":"de Passone C, GB, Franco RR, Ito SS, et al (2020) Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis. BMJ Paediatr Open 4:e000630. https:\/\/doi.org\/10.1136\/bmjpo-2019-000630","journal-title":"BMJ Paediatr Open"},{"key":"5327_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.endinu.2018.01.006","volume":"65","author":"E Moix Gil","year":"2018","unstructured":"Moix Gil E, Gim\u00e9nez-Palop O, Caix\u00e0s A (2018) Treatment with growth hormone in the prader-willi syndrome. Endocrinol Diabetes Nutr (Engl Ed) 65:229\u2013236. https:\/\/doi.org\/10.1016\/j.endinu.2018.01.006","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"5327_CR68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajmg.1320350306","volume":"35","author":"MG Butler","year":"1990","unstructured":"Butler MG (1990) Prader-Willi syndrome: current understanding of cause and diagnosis. Am J Med Genet 35:319\u2013332. https:\/\/doi.org\/10.1002\/ajmg.1320350306","journal-title":"Am J Med Genet"},{"key":"5327_CR69","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s12519-022-00653-y","volume":"19","author":"R-Q Cheng","year":"2023","unstructured":"Cheng R-Q, Ying Y-Q, Qiu Z-Q et al (2023) Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome. World J Pediatr 19:438\u2013449. https:\/\/doi.org\/10.1007\/s12519-022-00653-y","journal-title":"World J Pediatr"},{"key":"5327_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2020.102084","volume":"83","author":"X Yang","year":"2020","unstructured":"Yang X (2020) Growth hormone treatment for Prader-Willi syndrome: a review. Neuropeptides 83:102084. https:\/\/doi.org\/10.1016\/j.npep.2020.102084","journal-title":"Neuropeptides"},{"key":"5327_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/apa.12813","volume":"104","author":"B B\u00f6hm","year":"2015","unstructured":"B\u00f6hm B, Ritz\u00e9n EM, Lindgren AC (2015) Growth hormone treatment improves vitality and behavioural issues in children with Prader-Willi syndrome. Acta Paediatr 104:59\u201367. https:\/\/doi.org\/10.1111\/apa.12813","journal-title":"Acta Paediatr"},{"key":"5327_CR72","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12020-020-02547-3","volume":"71","author":"Y Luo","year":"2021","unstructured":"Luo Y, Zheng Z, Yang Y et al (2021) Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials. Endocrine 71:321\u2013330. https:\/\/doi.org\/10.1007\/s12020-020-02547-3","journal-title":"Endocrine"},{"key":"5327_CR73","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1210\/jc.2002-021536","volume":"88","author":"AM Haqq","year":"2003","unstructured":"Haqq AM, Stadler DD, Jackson RH et al (2003) Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 88:2206\u20132212. https:\/\/doi.org\/10.1210\/jc.2002-021536","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-016-0535-7","volume":"11","author":"RJ Kuppens","year":"2016","unstructured":"Kuppens RJ, Mahabier EF, Bakker NE et al (2016) Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial. Orphanet J Rare Dis 11:153. https:\/\/doi.org\/10.1186\/s13023-016-0535-7","journal-title":"Orphanet J Rare Dis"},{"key":"5327_CR75","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1352\/1944-7558-120.4.315","volume":"120","author":"ST Lo","year":"2015","unstructured":"Lo ST, Festen DAM, Lind T-d, van Wijngaarden RFA et al (2015) Beneficial effects of long-term growth hormone treatment on adaptive functioning in infants with Prader-Willi syndrome. Am J Intellect Dev Disabil 120:315\u2013327. https:\/\/doi.org\/10.1352\/1944-7558-120.4.315","journal-title":"Am J Intellect Dev Disabil"},{"key":"5327_CR76","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s004310050075","volume":"159","author":"U Eiholzer","year":"2000","unstructured":"Eiholzer U, Malich S, I\u2019Allemand D (2000) Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome? Eur J Pediatr 159:299. https:\/\/doi.org\/10.1007\/s004310050075","journal-title":"Eur J Pediatr"},{"key":"5327_CR77","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1515\/jpem.2004.17.4.591","volume":"17","author":"B Whitman","year":"2004","unstructured":"Whitman B, Carrel A, Bekx T et al (2004) Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months. J Pediatr Endocrinol Metab 17:591\u2013600. https:\/\/doi.org\/10.1515\/jpem.2004.17.4.591","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5327_CR78","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1365-2265.2007.03126.x","volume":"68","author":"D Festen","year":"2008","unstructured":"Festen D, a. M, Wevers M, Lindgren AC, et al (2008) Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) 68:919\u2013925. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03126.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5327_CR79","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1210\/jcem.87.4.8414","volume":"87","author":"AL Carrel","year":"2002","unstructured":"Carrel AL, Myers SE, Whitman BY, Allen DB (2002) Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 87:1581\u20131585. https:\/\/doi.org\/10.1210\/jcem.87.4.8414","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1067\/mpd.2000.105369","volume":"137","author":"SE Myers","year":"2000","unstructured":"Myers SE, Carrel AL, Whitman BY, Allen DB (2000) Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 137:42\u201349. https:\/\/doi.org\/10.1067\/mpd.2000.105369","journal-title":"J Pediatr"},{"key":"5327_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-022-00653-y","author":"R-Q Cheng","year":"2022","unstructured":"Cheng R-Q, Ying Y-Q, Qiu Z-Q et al (2022) Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome. World J Pediatr. https:\/\/doi.org\/10.1007\/s12519-022-00653-y","journal-title":"World J Pediatr"},{"key":"5327_CR82","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ajmg.a.32137","volume":"146A","author":"U Eiholzer","year":"2008","unstructured":"Eiholzer U, Meinhardt U, Rousson V et al (2008) Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10. Am J Med Genet A 146A:873\u2013880. https:\/\/doi.org\/10.1002\/ajmg.a.32137","journal-title":"Am J Med Genet A"},{"key":"5327_CR83","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s13023-021-01952-9","volume":"16","author":"HJ Hirsch","year":"2021","unstructured":"Hirsch HJ, Gross-Tsur V (2021) Growth hormone treatment for adults with Prader-Willi syndrome: another point of view. Orphanet J Rare Dis 16:337. https:\/\/doi.org\/10.1186\/s13023-021-01952-9","journal-title":"Orphanet J Rare Dis"},{"key":"5327_CR84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000342649","volume":"78","author":"A Salvatoni","year":"2012","unstructured":"Salvatoni A, Berini J, Chiumello G et al (2012) POI: a score to modulate GH treatment in children with Prader-Willi syndrome.\u00a0Horm Res Paediatr\u00a078:201\u2013202. https:\/\/doi.org\/10.1159\/000342649","journal-title":"Hormone Research in Paediatrics"},{"key":"5327_CR85","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1210\/clinem\/dgab746","volume":"107","author":"V Bamba","year":"2022","unstructured":"Bamba V, Kanakatti Shankar R (2022) Approach to the patient: safety of growth hormone replacement in children and adolescents. J Clin Endocrinol Metab 107:847\u2013861. https:\/\/doi.org\/10.1210\/clinem\/dgab746","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR86","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1515\/jpem-2018-0539","volume":"32","author":"R Corripio","year":"2019","unstructured":"Corripio R, Tubau C, Calvo L et al (2019) Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study. J Pediatr Endocrinol Metab 32:879\u2013884. https:\/\/doi.org\/10.1515\/jpem-2018-0539","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5327_CR87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4274\/jcrpe.galenos.2019.2018.0277","volume":"11","author":"M Gaddas","year":"2019","unstructured":"Gaddas M, P\u00e9rin L, Le Bouc Y (2019) Evaluation of IGF1\/IGFBP3 molar ratio as an effective tool for assessing the safety of growth hormone therapy in small-for-gestational-age, growth hormone-deficient and Prader-Willi children. J Clin Res Pediatr Endocrinol 11:253\u2013261. https:\/\/doi.org\/10.4274\/jcrpe.galenos.2019.2018.0277","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"5327_CR88","doi-asserted-by":"publisher","first-page":"e3634","DOI":"10.1210\/clinem\/dgab300","volume":"106","author":"HH Shukur","year":"2021","unstructured":"Shukur HH, Hussain-Alkhateeb L, Farholt S et al (2021) Effects of growth hormone treatment on sleep-related parameters in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 106:e3634\u2013e3643. https:\/\/doi.org\/10.1210\/clinem\/dgab300","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR89","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/jpc.15691","volume":"58","author":"D Caudri","year":"2022","unstructured":"Caudri D, Nixon GM, Nielsen A et al (2022) Sleep-disordered breathing in Australian children with Prader-Willi syndrome following initiation of growth hormone therapy. J Paediatr Child Health 58:248\u2013255. https:\/\/doi.org\/10.1111\/jpc.15691","journal-title":"J Paediatr Child Health"},{"key":"5327_CR90","doi-asserted-by":"publisher","first-page":"E1516","DOI":"10.1210\/jc.2013-1831","volume":"98","author":"J Berini","year":"2013","unstructured":"Berini J, Spica Russotto V, Castelnuovo P et al (2013) Growth hormone therapy and respiratory disorders: long-term follow-up in PWS children. J Clin Endocrinol Metab 98:E1516\u2013E1523. https:\/\/doi.org\/10.1210\/jc.2013-1831","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/EJE-21-0211","volume":"185","author":"LN Grootjen","year":"2021","unstructured":"Grootjen LN, Rutges JPHJ, Damen L et al (2021) Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. Eur J Endocrinol 185:47\u201355. https:\/\/doi.org\/10.1530\/EJE-21-0211","journal-title":"Eur J Endocrinol"},{"key":"5327_CR92","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1573396315666190716120925","volume":"15","author":"MG Butler","year":"2019","unstructured":"Butler MG, Miller JL, Forster JL (2019) Prader-Willi syndrome - clinical genetics, diagnosis and treatment approaches: an update. Curr Pediatr Rev 15:207\u2013244. https:\/\/doi.org\/10.2174\/1573396315666190716120925","journal-title":"Curr Pediatr Rev"},{"key":"5327_CR93","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.3390\/jcm12123967","volume":"12","author":"Y Couto-Rosende","year":"2023","unstructured":"Couto-Rosende Y, Garcia-Tirado D, Palacio-Marco M et al (2023) A personalized approach to determining the caloric needs of children with Prader-Willi syndrome treated with growth hormone. J Clin Med 12:3967. https:\/\/doi.org\/10.3390\/jcm12123967","journal-title":"J Clin Med"},{"key":"5327_CR94","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5114\/pedm.2022.112861","volume":"28","author":"M Drabik","year":"2022","unstructured":"Drabik M, Lewi\u0144ski A, Stawerska R (2022) Management of Prader-Labhart-Willi syndrome in children and in adults, with particular emphasis on the treatment with recombinant human growth hormone. Pediatr Endocrinol Diabetes Metab 28:64\u201374. https:\/\/doi.org\/10.5114\/pedm.2022.112861","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"5327_CR95","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ajmg.a.31468","volume":"143A","author":"SE Myers","year":"2007","unstructured":"Myers SE, Whitman BY, Carrel AL et al (2007) Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A 143A:443\u2013448. https:\/\/doi.org\/10.1002\/ajmg.a.31468","journal-title":"Am J Med Genet A"},{"key":"5327_CR96","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jpeds.2004.08.002","volume":"145","author":"AL Carrel","year":"2004","unstructured":"Carrel AL, Moerchen V, Myers SE et al (2004) Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr 145:744\u2013749. https:\/\/doi.org\/10.1016\/j.jpeds.2004.08.002","journal-title":"J Pediatr"},{"key":"5327_CR97","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1210\/jc.2009-1389","volume":"95","author":"AL Carrel","year":"2010","unstructured":"Carrel AL, Myers SE, Whitman BY et al (2010) Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab 95:1131\u20131136. https:\/\/doi.org\/10.1210\/jc.2009-1389","journal-title":"J Clin Endocrinol Metab"},{"key":"5327_CR98","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1515\/jpem-2001-0805","volume":"14","author":"AL Carrel","year":"2001","unstructured":"Carrel AL, Myers SE, Whitman BY, Allen DB (2001) Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. J Pediatr Endocrinol Metab 14:1097\u20131105. https:\/\/doi.org\/10.1515\/jpem-2001-0805","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5327_CR99","doi-asserted-by":"publisher","first-page":"E35","DOI":"10.1542\/peds.109.2.e35","volume":"109","author":"BY Whitman","year":"2002","unstructured":"Whitman BY, Myers S, Carrel A, Allen D (2002) The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Pediatrics 109:E35. https:\/\/doi.org\/10.1542\/peds.109.2.e35","journal-title":"Pediatrics"},{"key":"5327_CR100","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000437141","volume":"84","author":"NE Bakker","year":"2015","unstructured":"Bakker NE, Siemensma EPC, van Rijn M et al (2015) Beneficial effect of growth hormone treatment on health-related quality of life in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. Horm Res Paediatr 84:231\u2013239. https:\/\/doi.org\/10.1159\/000437141","journal-title":"Horm Res Paediatr"},{"key":"5327_CR101","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/j.1651-2227.2010.01904.x","volume":"99","author":"I Sipil\u00e4","year":"2010","unstructured":"Sipil\u00e4 I, Sintonen H, Hietanen H et al (2010) Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome. Acta Paediatr 99:1712\u20131718. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01904.x","journal-title":"Acta Paediatr"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05327-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-05327-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-05327-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T14:09:37Z","timestamp":1710857377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-05327-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5327"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-05327-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a review work; consequently, ethical approval is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}